The transmembrane topography of the rat hepatocyte ectoenzyme 5'-nucleotidase was studied by the use of glycoprotein labelling and limited-proteolysis techniques. Comparison, by one-dimensional peptide mapping, of enzyme iodinated from outside the cell with that iodinated in the solubilized state showed that no additional iodination sites were revealed on solubilization. Incubation of newly synthesized enzyme in a microsomal membrane fraction with proteinase showed that the entire molecule of 5'-nucleotidase was protected from proteolysis. These data suggest that little, if any, of the 5'-nucleotidase molecule is present on the cytoplasmic side of the plasma membrane. No evidence was found for a previously proposed interaction between 5'-nucleotidase and actin, although the ability of preparations of 5'-nucleotidase to prevent inhibition of deoxyribonuclease I by actin was explained by minute traces of ATPase activity.
INTRODUCTION
5'-Nucleotidase (EC 3.1.3.5) is an intrinsic membrane glycoprotein found in the plasma membrane of several cell types. It is an ectoenzyme, with its active site on the external face of the plasma membrane (De Pierre & Karnowsky, 1974; Newby et al., 1975) . Although no single physiological role has been assigned to the enzyme, several have been suggested, including nucleotide scavenging or production of adenosine as a 'local hormone' (Stanley et al., 1982). 5'-Nucleotidase is widely used as a general plasmamembrane marker, although the enzyme appears to be concentrated in certain domains of polar epithelial (or epithelium-derived) cells, such as hepatocytes (Wisher & Evans, 1975) and intestinal epithelial cells (Gratecos et al., 1978) . In addition, up to 50% of the enzyme (depending on cell type) is found intracellularly, primarily in an endocytotic recycling pool (Stanley et al., 1980; Widnell et al., 1982) , but also in lysosomes (Maguire & Luzio, 1985) , in vesicles involved in the transcytosis of polymeric IgA (Mullock et al., 1983) and in the Golgi apparatus (Farquhar et al., 1974; Little & Widnell, 1975) . It has been suggested that 5'-nucleotidase interacts with the cytoskeleton, either directly with actin (Mannherz & Rohr, 1978) or in an unspecified manner (Carraway et al., 1979) . Such an interaction would be extremely interesting, given the widespread distribution of the enzyme in subcellular compartments and its movement through nucleated cells on endocytic routes (Stanley et al., 1980; Widnell, 1983) . The studies reported, however, have relied on indirect evidence (Carraway et al., 1979) or at best partially purified preparations of 5'-nucleotidase (Mannherz & Rohr, 1978) . In addition, the only evidence that 5'-nucleotidase is a transmembrane protein, and therefore possesses a domain capable of interacting with intracellular actin, comes from studies on a cell line with aberrant insertion of 5'-nucleotidase (Zachowski et al., 1981) . In order to investigate properly the mechanism by which enzyme circulates through the cell, and is segregated into different membrane domains, we have undertaken a study of the structure of the enzyme, its membrane topography and its interaction with cytoplasmic proteins.
Previous work in this laboratory has developed a method of immuno-purifying 5'-nucleotidase from rat liver (Bailyes et al., 1982) and shown that the enzyme is an integral membrane protein and normally exists as a homodimer of-approx.-70000-Mr (a-)subunits, each subunit possessing an enzymically active site (Bailyes et al., 1984) . About 20% of the enzyme is found as a heterodimer of a-and f-subunits. The fl-subunit has Mr approx. 38000, and can be shown to be related to the a-subunit by Western blotting and peptide mapping (Bailyes et al., 1984) .
We now report the use of peptide mapping and proteolytic cleavage to show the absence of a significant cytoplasmic portion of 5'-nucleotidase. In 
Antibodies
A non-inhibitory monoclonal murine antibody to rat liver 5'-nucleotidase (5NE5) and a rabbit antiserum to immuno-purified 5'-nucleotidase (209) have previously been reported (Bailyes et al., 1984) . Monoclonal antibody was coupled to cellulose to make a solid-phase immunoadsorbent as previously described (Siddle et al., 1981) . A control immunoadsorbent (X63) was made by using IgG from the original myeloma line. An immunoglobin fraction of 209 antiserum was made by Na2SO4 precipitation (Williams & Chase, 1967) . Antiserum to rat secretory component (a fragment of the receptor for polymeric IgA) was a gift from Dr. J. Peppard. 5'-Nucleotidase 5'-Nucleotidase was purified from rat liver, assayed and iodinated essentially as previously described (Bailyes et al., 1982) , except where otherwise described in the text.
Electrophoresis
Electrophoresis in polyacrylamide gels was by the method of Laemmli (1970) Proteins were detected by fluorography with pre-flashed film (Laskey & Mills, 1975) or by autoradiography with Cronex Quanta or Lightning Plus intensifying screens (du Pont). Binding of 125I-actin to protein in electrophoresis gels was by the method of Snabes et al. (1981) .
Hepatocytes
Isolated rat hepatocytes were prepared essentially by the method of Berry (1974) . Cells with improved maintenance of viability were obtained by further purification in a Percoll gradient (Dalet et al., 1982) . Cell viability was assessed by morphology under phase-contrast microscopy and by ability to exclude Trypan Blue.
Surface labelling (a) With 1251. Plastic scintillation vials were coated with iodogen (1,3,4,6-tetrachloro-3,6-diphenylglycoluril) (Paul, 1975) containing 20 mM-Hepes and 3 mM-CaC12 for 21 h on ice with 200 ,tg of iodogen and 0.5 mCi of Na1251. The cells were then collected by centrifugation (100 g for 2 min) and washed three times with 5 mM-KI in Hanks balanced salt solution.
(b) With 3H. Glycoproteins were labelled with NaB3H4 by a modification of the methods of Gahmberg & Anderson (1977) . Sialic acid residues were oxidized by incubating 3 x 108 cells in 20 ml of buffer H (50 mM-sodium phosphate buffer, pH 7.5, containing 0.15 M-NaCl, 1 mM-CaCl2, 1 mM-MgCl2 and 1 % (w/v) bovine serum albumin) containing 1 mM-NaIO4 for 10 min at 0 'C. Galactose residues were oxidized by incubating the same number of cells in buffer H with 40 units of neuraminidase and 40 units of galactose oxidase for 60 min at 4 'C. In both cases cells were washed three times in buffer H and resuspended to a total of 15 ml. Since NaBH4 is rapidly hydrolysed at pH 7.5, cells were given four consecutive treatments with 5 mCi of NaB3H4 for 15 min at 4 'C. Cells were then washed once in buffer H and three times in PBS (50 mM-sodium phosphate buffer, pH 7.5, containing 0.15 M-NaCl).
Immunoadsorption of 5'-nucleotidase
Surface-labelled cells were suspended in PBS containing 1 mM-phenylmethanesulphonyl fluoride, disrupted by freeze-thawing and sonication, and a membrane pellet was prepared by centrifuging at 100000 g for 1 h. This pellet was resuspended in PBS/phenylmethanesulphonyl fluoride and solubilized in 2% (w/v) sulphobetaine 14 for 20 min at 22 'C and 10 min at 37 'C. Insoluble material was removed by centrifugation (125000 g for 30 min). To the supernatant was added I vol. of2% (w/v) gelatin and 5vol. of 5-fold concentrate of RIPEA [50 mM-Tris/HCl buffer, pH 7.5, containing 1 % (v/v) Triton X-100, 1%
(w/v) sodium deoxycholate, 0.1 % SDS, 1 mm EDTA and 0.15 M-NaCl]. 5'-Nucleotidase was extracted by approx. 0.3 mg of solid-phase antibody 5NE5 per 108 cells, or by a similar amount of solid-phase X63 antibody, for 16 h at 4 'C. The immunoadsorbent was then washed once in RIPEA, twice in RIPEA containing 0.5 M-NaCl and twice in 10 mM-Tris/HCl buffer, pH 7.5, before being extracted with sample buffer (Laemmli, 1970) containing 2% SDS, for electrophoresis.
Protein labelling in primary cultured hepatocytes
Primary cultures were prepared essentially as described by Tanaka et al. (1978) , and grown on 50 mm collagen-coated dishes for 2 days before use in labelling studies. Before labelling, cells were incubated for 2 h in methionine-free basal Eagle's medium supplemented with non-essential amino acids and containing 10% (v/v) dialysed foetal-calf serum, 0.03 /uM-insulin and 10 /Mdexamethasone. Cells were then incubated in the same medium containing 0.125 ,uCi of [35S]methionine/ml for 15 min. Cells were harvested in 2 ml of PBS per plate and disrupted with 70 strokes of a tight-fitting Dounce homogenizer. A microsomal fraction (Owen et al., 1980) was prepared by centrifuging the broken cells at 1500 g for 10 min and centrifuging the resultant supernatant at 100000 g for 1 h. Microsomal membranes were incubated for 1 h at 37 'C in PBS with or without 350 jug of proteinase K/ml. Proteolysis was stopped by the addition of bovine serum albumin to 10 mg/ml and phenylmethanesulphonyl fluoride to 2 mM.
Immunoprecipitation of proteins from microsomal membranes 5'-Nucleotidase and a control transmembrane protein, the receptor for polymeric IgA, were separately purified from membranes of pulse-labelled cells by using polyclonal antisera. Membranes were incubated with 64 gg of 209 antibody fraction/ml, 1/100 dilution of rabbit anti-(rat secretory component) antibody or control rabbit IgG, in the presence of 0.1 % (v/v) Triton X-100, for 16 h at 4 'C. Membranes were then diluted 30-fold in PBS/phenylmethanesulphonyl fluoride and collected by centrifugation (125000 g for 45 min), solubilized in 2% (w/v) sulphobetaine 14 and centrifuged for 10 min at 120 000 g to remove debris. The supernatants were then incubated for 2 h at 22 'C with 20 mg of protein A-Sepharose/ml. The protein A-Sepharose was then spun down, washed three times with PBS containing 0.05% (v/v) Tween 20, once with RIPEA, once more with PBS/Tween, and twice with 10 mM-Tris/HCl buffer, pH 7.5. Samples were then prepared for electrophoresis as described for the immunoadsorbent. Other assays ATP was measured by using the firefly luminescence assay (Addanki et al., 1966) . Deoxyribonuclease I was measured by the hyperchromicity assay (Blickstad et al., 1978) . The effect of 5'-nucleotidase on actin was determined by a modification of the method of Rohr & Mannherz (1979) . Actin (50 #g/ml) was incubated with or without 5'-nucleotidase, in 100 1l of buffer (50 mmTris/HCl buffer, pH 7.5, containing 1 mM-CaCl2, 1 mM-MgSO4 and 0.0500 sulphobetaine 14). After incubation, 10 41 of 20 #g/ml deoxyribonuclease I was added, and 50 #1 of the resultant mixture was assayed for deoxyribonuclease I activity.
RESULTS

Cytoplasmic domain
Methods for demonstrating a cytoplasmic domain in an integral membrane protein have been discussed previously (Etemadi, 1980; Warren 1981 ); short of sequencing the entire molecule, there are two commonly used approaches, either labelling proteins or proteolytic cleavage of proteins, on one side of the membrane or the other. Both approaches have been used in the present study of 5'-nucleotidase.
Isolated hepatocytes (viability > 98%) were surfacelabelled with 1251 and 5'-nucleotidase was isolated by immunoadsorption (Fig. 1) . The iodination was performed at 0 'C in order to maintain the viability of the hepatocytes in the absence of bovine serum albumin, and for this reason iodogen was used rather than lactoperoxidase to catalyse the reaction. Under these conditions, some iodine penetrates the cells, but this was largely (88%) soluble in ice-cold trichloroacetic acid (10% (w/v)), and the specific radioactivity of iodine in proteins from the high-speed supernatant (crude cytoplasmic fraction) was less than 1/600th that of the membrane 5'-nucleotidase. purified enzyme with the use of a range of proteinase concentrations (Fig. 2) . In these gels, which contained a high concentration of acrylamide, the apparent Mr of the 5'-nucleotidase monomer (84000) was higher than that normally observed. This is probably due to anomalous migration of this glycoprotein, leading to a higher apparent Mr in the 17.5% acrylamide gel. Proteinase at 75 ng per track was used to produce maps of the two forms of labelled enzyme (Fig. 3) . The two maps were identical, both in size of fragment produced and in relative amounts of label in each fragment, apart from small differences due to unavoidable interexperimental variability in the degree of proteolysis (compare Fig. 3 with Fig. 2 , 75 ng track). Proteolytic cleavage of the cytoplasmic domain of a membrane protein has been used to demonstrate transmembrane insertion (e.g. Owen et al., 1980; Sutherland et al., 1984; von Figura et al., 1985) . Treatment of newly synthesized microsomal proteins with proteinase K (Owen et al., 1980) failed to cleave the 5'-nucleotidase (Fig. 4, lane a) , indicating that the whole length of the protein was inaccessible in the vesicle and no cytoplasmic domain was present. The difference in Mr of the immature microsomal protein and the normal enzyme, about 5000, is probably due to the different amount and type ofcarbohydrate on the two forms of the enzyme.
When receptor for polymeric IgA was isolated after similar treatment with proteinase K, a decrease in Mr approx. 15 000 was observed (Fig. 4) in vivo (Sztul et al., 1985) and with the cytoplasmic tail of rabbit receptor for polymeric IgA deduced from the cDNA sequence (Mostov et al., 1984 (Fig. 5a ) and subjected to V8 proteinase cleavage as for the '251-labelled protein (Fig. Sb) . Sialic acid removal (galactose-labelled protein) caused a decrease in apparent Mr of approx. 3000 (Fig. Sa) , accounting for 60% of the difference in molecular mass of mature and immature forms of the enzyme (Fig. 4) . The V8-proteinase-cleavage map showed that carbohydrate is found mostly in the same 24000-Mr fragment as the iodination sites.
Interaction with actin
It has previously been shown (Mannherz & Rohr, 1978) that 5'-nucleotidase prevents the inhibition of Vol. 236 499 Table 1 . Inhibition of 5'-nucleotidase by actin 5'-Nucleotidase activity was measured in 1.2 x 105 isolated rat hepatocytes (viability > 92%) or in purified enzyme (2 munits) in the presence or in the absence of actin in the monomeric (G) or the polymerized (F) state. Actin was dialysed against 50 mM-Tris/HCl buffer, pH 7.5, containing 0.1 mM-CaCl2 and 50 ,sM-ATP, with (F) or without (G) 100 mM-KCl and 0.2 mM-MgC12. 5'-Nucleotidase was determined spectrophotometrically (Ipata, 1967) deoxyribonuclease I by actin, and it was suggested that this indicated direct interaction of the membrane enzyme with the cytoskeleton. We found that some preparations of purified rat liver 5'-nucleotidase did prevent deoxyribonuclease inhibition by actin, but that this effect correlated with a contaminating (approx. 0.0002%) ATPase activity in these preparations, rather than with 5'-nucleotidase activity (Fig. 6 ). In addition, no effect of 5'-nucleotidase on actin inhibition of deoxyribonuclease was found in the presence of 200 ,tM-ATP (results not shown). F-actin has been reported to inhibit chick gizzard 5'-nucleotidase . Rat liver 5'-nucleotidase was only inhibited by G-actin ( (Schleicher et al., 1984; Stratford & Brown, 1985) . No binding of actin to 5'-nucleotidase was detected (Fig. 7) , although gelsolin, a known actin-binding protein (Yin et al., 1981) , was labelled normally.
DISCUSSION
The study ofthe differential labelling of 5'-nucleotidase, either at all accessible sites (soluble enzyme) or at extracytoplasmic sites (cell-surface enzyme), though strongly suggesting the absence of a cytoplasmic end to 5'-nucleotidase, allows us to conclude only that the enzyme possesses no iodinatable sites on the cytoplasmic side of the plasma membrane. The insensitivity of newly synthesized enzyme, the extracytoplasmic portion of which is protected by being inside the microsomal membrane, to proteinase K strongly suggests that there is no significant (i.e. no more than four or five amino acid residues) cytoplasmic domain in 5'-nucleotidase. We estimate that loss of more than five amino acid residues would give rise to an observable decrease in Mr in the gels used.
The major biochemical evidence in favour of a cytoplasmic domain is the putative interaction with the cytoskeleton. Such an interaction would be important in providing an attachment point for the cytoskeleton in the membrane, and a means of moving 5'-nucleotidasecontaining vesicles through the cell. It has been shown that the effect of cytoskeletal drugs on inhibition of 5'-nucleotidase by concanavalin A (Carraway et al., 1979) is not due to a direct interaction of enzyme and cytoskeleton (Craik et al., 1985) . We have found that the effects of 5'-nucleotidase on actin inhibition ofdeoxyribonuclease are due to contaminating ATPases, which has also been shown for chick gizzard 5'-nucleotidase . The ability of actin to inhibit deoxyribonucleotidase I is lost on incubation at 37°C in the absence of ATP (results not shown), an effect that appears to be speeded up by the presence ofATPases and to be related to loss ofactin-bound nucleotide . The interaction with F-actin proposed for this chick gizzard 5'-nucleotidase, associated with enzyme inhibition, does not occur with pure rat liver 5'-nucleotidase. This may be due to basic differences in these two enzymes, as antibodies against chick gizzard enzyme label only the endothelial cells in rat liver and not hepatocytes (Heidemann et al., 1985) , suggesting an absence ofcommonantigenic determinants. Theinhibition of 5'-nucleotidase activity caused by G-actin also occurs with enzyme located on the outside of intact cells, indicating that it is a direct effect on the extracytoplasmic portion of the enzyme, and not a normal physiological effect. There is therefore neither structural nor biochemical evidence for a cytoplasmic domain in the liver 5'-nucleotidase, although final confirmation will depend on cloning and sequencing the protein.
Short cytoplasmic domains are not unknown in plasma-membrane-located proteins [e.g. interleukin-2 receptor, 11 amino acid residues (Cosman et al., 1984) , and Sindbis-virion coat protein El, two amino acid residues (Rice & Strauss, 1981) ]. Ifthe cell depends on the cytoplasmic domain of a protein to determine its location, then the signal must be very tightly encoded. However, evidence from hybrid proteins suggests that the cytoplasmic domain may not be, itself, sufficient for sorting. Alterations to the cytoplasmic domain of vesicular-stomatitis-virus G protein can prevent or inhibit its passage through the Golgi apparatus to the cell surface (Rose & Bergmann, 1983) . However, exchange of its extracellular domain for the sequence of a secreted protein, growth hormone, also prevents passage of the protein beyond the Golgi apparatus (Guan & Rose, 1984) , and N-linked glycosylation appears to be essential for correct insertion at the cell surface (Guan et al., 1985) . Information concerned with sorting 5'-nucleotidase in the liver cell may therefore exist in its extracytoplasmic domains.
5'-Nucleotidase is an integral membrane protein in that it normally requires detergent to be solubilized. Attempts to release the enzyme from membranes by proteolysis gave low yields (Bailyes, 1982) , indicating that 5'-nucleotidase belongs to the group of short-stalked ectoenzymes identified by Kenny et al. (1983) . However, release of the active enzyme has been achieved with phosphotidylinositol-specific phospholipase C (Low & Finean, 1978; Shukla et al., 1980) , suggesting an important role for phosphatidylinositol in anchoring the protein in the membrane. It is not yet clear whether the protein is itself inserted into the membrane, with a very small extension into the cytoplasm, similar to several microvillar peptidases (Kenny & Maroux, 1982; Kenny et al., 1983) , or the enzyme is anchored by a non-protein addition to one end, as has been suggested for the Thy-l antigen (Williams & Gagnon, 1982; Low & Kincade, 1985) .
The structure of the extracellular domain has also shown several interesting features, notably the presence ofone section containing both the glycan chains and most of the iodinatable sites in the molecule. This section may be that most exposed at the surface of the cell when the protein is inserted in the membrane. Since concanavalin A is a potent inhibitor of 5'-nucleotidase (Riordan & Slavik, 1974) , it is probable that this section of the molecule also contains the active site. Since the molecule normally occurs as a non-covalently linked homodimer (Bailyes et al., 1984) , another part of the surface of the molecule must form the inter-subunit binding region. The a-subunit therefore contains at least three domains: the membrane anchor plus short stalk, the inter-subunit binding region, and the exposed surface, containing attached carbohydrate, most of the accessible iodination sites and the active site. This last domain is formed by a single section of the polypeptide chain, with an Mr of approx. 24000.
